Transcription of FINAL CLINICAL STUDY REPORT
{{id}} {{{paragraph}}}
Example: quiz answers
FINAL CLINICAL STUDY REPORT
MAPS CLINICAL STUDY REPORT MP-2 15-SEP-2011 Page 1 of 62 FINAL CLINICAL STUDY REPORT Protocol #: MP- 2 IND #: 63,384 September 15, 2011 First Subject First Visit: July 18, 2006 Last Subject Last Visit: January 10, 2011 Phase Two Pilot STUDY : 3,4-methylenedioxymethamphetamine (MDMA)-assisted Psychotherapy in Patients with Treatment-resistant Posttraumatic Stress Disorder (PTSD) A randomized, single-center, active placebo-controlled, double-blind, partial crossover STUDY comparing response to psychotherapy assisted by 25mg or 125 mg MDMA.
MAPS Clinical Study Report MP-2 15-SEP-2011 MP-2_CSR_FINAL_15SEP11.pdf Page 5 of 62 Name of Sponsor: Multidisciplinary Association for Psychedelic Studies (MAPS)
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: